Uma Menon Sachdeva, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophageal Neoplasms | 12 | 2024 | 1668 | 3.020 |
Why?
|
Esophagectomy | 4 | 2023 | 481 | 1.240 |
Why?
|
Adenocarcinoma | 6 | 2024 | 6395 | 0.920 |
Why?
|
Stomach Neoplasms | 2 | 2024 | 1481 | 0.840 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2024 | 596 | 0.790 |
Why?
|
Organoids | 6 | 2024 | 743 | 0.720 |
Why?
|
Neoadjuvant Therapy | 3 | 2023 | 2907 | 0.540 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1351 | 0.530 |
Why?
|
Cell Survival | 3 | 2024 | 5777 | 0.500 |
Why?
|
Pneumonectomy | 1 | 2022 | 1156 | 0.500 |
Why?
|
Precancerous Conditions | 1 | 2021 | 985 | 0.450 |
Why?
|
Cell Lineage | 1 | 2021 | 2575 | 0.390 |
Why?
|
Autophagy | 3 | 2021 | 1349 | 0.380 |
Why?
|
Laparoscopy | 1 | 2023 | 2041 | 0.380 |
Why?
|
Lymph Nodes | 1 | 2022 | 3474 | 0.360 |
Why?
|
Retinoblastoma | 1 | 2012 | 321 | 0.320 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13586 | 0.300 |
Why?
|
Retinoblastoma Protein | 1 | 2012 | 671 | 0.300 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4362 | 0.300 |
Why?
|
Immunotherapy | 2 | 2024 | 4755 | 0.290 |
Why?
|
Cell Physiological Phenomena | 1 | 2008 | 152 | 0.270 |
Why?
|
Esophagus | 2 | 2024 | 1042 | 0.270 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 6974 | 0.260 |
Why?
|
Polyesters | 1 | 2024 | 377 | 0.200 |
Why?
|
Oxidation-Reduction | 3 | 2024 | 2227 | 0.200 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3948 | 0.180 |
Why?
|
Esophagogastric Junction | 1 | 2023 | 351 | 0.180 |
Why?
|
Racemases and Epimerases | 1 | 2021 | 113 | 0.180 |
Why?
|
NAD | 1 | 2024 | 618 | 0.170 |
Why?
|
Keratinocytes | 2 | 2024 | 876 | 0.170 |
Why?
|
Circadian Rhythm | 2 | 2009 | 2593 | 0.170 |
Why?
|
Cell Proliferation | 6 | 2024 | 10474 | 0.170 |
Why?
|
Oxidative Stress | 2 | 2021 | 3139 | 0.170 |
Why?
|
Lactic Acid | 1 | 2024 | 1140 | 0.160 |
Why?
|
Enzyme Activation | 1 | 2024 | 3590 | 0.150 |
Why?
|
Bronchoscopy | 1 | 2024 | 914 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2024 | 521 | 0.150 |
Why?
|
Obesity | 1 | 2020 | 13090 | 0.150 |
Why?
|
Ethanol | 2 | 2021 | 1331 | 0.150 |
Why?
|
Cisplatin | 1 | 2024 | 1660 | 0.150 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 17140 | 0.150 |
Why?
|
Gastrectomy | 1 | 2023 | 693 | 0.150 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 974 | 0.140 |
Why?
|
Paclitaxel | 1 | 2024 | 1733 | 0.140 |
Why?
|
Humans | 26 | 2024 | 768166 | 0.130 |
Why?
|
Thoracic Surgery | 1 | 2022 | 727 | 0.130 |
Why?
|
Nanoparticles | 2 | 2024 | 1985 | 0.130 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1271 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3556 | 0.110 |
Why?
|
Cell Communication | 1 | 2021 | 1660 | 0.110 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1667 | 0.110 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6124 | 0.110 |
Why?
|
Signal Transduction | 5 | 2024 | 23645 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3348 | 0.110 |
Why?
|
Drug Delivery Systems | 1 | 2024 | 2232 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1890 | 0.100 |
Why?
|
Animals | 12 | 2024 | 169246 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13676 | 0.100 |
Why?
|
Genes, Retinoblastoma | 1 | 2012 | 125 | 0.100 |
Why?
|
Citrates | 1 | 2011 | 134 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2023 | 81762 | 0.090 |
Why?
|
Ketoglutaric Acids | 1 | 2011 | 76 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2021 | 2846 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11244 | 0.090 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 2957 | 0.090 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8542 | 0.090 |
Why?
|
Mitochondria | 2 | 2021 | 3681 | 0.090 |
Why?
|
Societies, Medical | 1 | 2022 | 3968 | 0.090 |
Why?
|
Flavoproteins | 1 | 2009 | 40 | 0.080 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2021 | 297 | 0.080 |
Why?
|
Obesity, Morbid | 1 | 2020 | 1298 | 0.080 |
Why?
|
ATP Citrate (pro-S)-Lyase | 1 | 2009 | 21 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8647 | 0.070 |
Why?
|
Risk Factors | 3 | 2023 | 74944 | 0.070 |
Why?
|
Databases, Factual | 1 | 2022 | 8080 | 0.070 |
Why?
|
Logistic Models | 1 | 2020 | 13290 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4058 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2011 | 951 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2021 | 11669 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9419 | 0.060 |
Why?
|
Glycolysis | 2 | 2024 | 837 | 0.060 |
Why?
|
Mice | 6 | 2021 | 82029 | 0.050 |
Why?
|
Cell Cycle | 1 | 2012 | 2932 | 0.050 |
Why?
|
Glucose | 3 | 2011 | 4352 | 0.050 |
Why?
|
Cell Line | 4 | 2024 | 15597 | 0.050 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2024 | 304 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16726 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 13053 | 0.050 |
Why?
|
Chemokine CCL5 | 1 | 2023 | 214 | 0.050 |
Why?
|
Prognosis | 1 | 2022 | 30010 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2024 | 697 | 0.050 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2024 | 622 | 0.040 |
Why?
|
Barrett Esophagus | 1 | 2024 | 495 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2021 | 366 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2021 | 404 | 0.040 |
Why?
|
Drug Carriers | 1 | 2024 | 709 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20760 | 0.040 |
Why?
|
Chemokines | 1 | 2023 | 963 | 0.040 |
Why?
|
Neurodegenerative Diseases | 1 | 2008 | 1095 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 65371 | 0.040 |
Why?
|
Histones | 1 | 2009 | 2601 | 0.040 |
Why?
|
Male | 5 | 2024 | 364719 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2021 | 2014 | 0.040 |
Why?
|
Polymers | 1 | 2024 | 1630 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3284 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 757 | 0.030 |
Why?
|
Female | 4 | 2024 | 397192 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1074 | 0.030 |
Why?
|
Aged | 3 | 2024 | 171504 | 0.030 |
Why?
|
Propensity Score | 1 | 2022 | 1969 | 0.030 |
Why?
|
Liver | 1 | 2009 | 7577 | 0.030 |
Why?
|
Protein Kinases | 1 | 2020 | 1611 | 0.030 |
Why?
|
Middle Aged | 3 | 2024 | 223492 | 0.030 |
Why?
|
Fibroblasts | 1 | 2023 | 4176 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18349 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2024 | 3703 | 0.030 |
Why?
|
RNA Interference | 2 | 2011 | 2832 | 0.020 |
Why?
|
Carboxylic Acids | 1 | 2011 | 91 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2062 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2011 | 354 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2011 | 193 | 0.020 |
Why?
|
Cell Nucleus | 2 | 2009 | 2885 | 0.020 |
Why?
|
Citric Acid Cycle | 1 | 2011 | 234 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 19015 | 0.020 |
Why?
|
Cryptochromes | 1 | 2009 | 49 | 0.020 |
Why?
|
Acetate-CoA Ligase | 1 | 2009 | 9 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2982 | 0.020 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2009 | 85 | 0.020 |
Why?
|
Ribonucleotides | 1 | 2009 | 114 | 0.020 |
Why?
|
Acetyl Coenzyme A | 1 | 2009 | 74 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2011 | 662 | 0.020 |
Why?
|
ARNTL Transcription Factors | 1 | 2009 | 97 | 0.020 |
Why?
|
Citric Acid | 1 | 2009 | 124 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8744 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3288 | 0.020 |
Why?
|
Glutamine | 1 | 2011 | 577 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2021 | 4045 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9561 | 0.020 |
Why?
|
Immunoblotting | 1 | 2011 | 1647 | 0.020 |
Why?
|
Models, Biological | 1 | 2024 | 9495 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8741 | 0.020 |
Why?
|
Interleukin-3 | 1 | 2009 | 425 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2009 | 488 | 0.020 |
Why?
|
Protein Stability | 1 | 2009 | 580 | 0.020 |
Why?
|
3T3 Cells | 1 | 2009 | 1084 | 0.020 |
Why?
|
Culture Media | 1 | 2009 | 898 | 0.020 |
Why?
|
Mutation | 1 | 2012 | 30238 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22291 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5341 | 0.020 |
Why?
|
Acetylation | 1 | 2009 | 1056 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 1683 | 0.020 |
Why?
|
Lung | 1 | 2024 | 10099 | 0.020 |
Why?
|
Apoptosis | 1 | 2021 | 9523 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 1743 | 0.020 |
Why?
|
Food | 1 | 2009 | 768 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2009 | 717 | 0.010 |
Why?
|
Cytoplasm | 1 | 2009 | 1505 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2009 | 778 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1143 | 0.010 |
Why?
|
Neoplasms | 2 | 2011 | 22371 | 0.010 |
Why?
|
Adipocytes | 1 | 2009 | 1197 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8748 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1656 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22379 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3740 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15832 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8317 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5797 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54926 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7608 | 0.010 |
Why?
|
United States | 1 | 2023 | 73039 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11928 | 0.010 |
Why?
|